Mechanisms associated to impaired activity of cardiac P-type ATPases in endothelial nitric oxide synthase knockout mice

Journal of Physiology and Biochemistry

Volumn 69, Issue 2, 2013, Pages 207-214

  Rezende, Daniele C ^a   Pôças, Elisa S C ^b   Muzi Filho, Humberto ^a   Cunha, Valéria M N ^a   Caricati Neto, Afonso ^c   Jurkiewicz, Aron ^c   Noël, François ^a   Quintas, Luis E M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Ciência e Tecnologia Do Rio de Janeiro   (Brazil)

^c FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Ca 2+ ATPase; eNOS knockout mice; Na+ K+ ATPase; Nitric oxide; Oxidative stress

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ENDOTHELIAL NITRIC OXIDE SYNTHASE; PHOSPHOLAMBAN; THIOL GROUP;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATALYSIS; CONTROLLED STUDY; ELECTRIC POTENTIAL; ENZYME ACTIVITY; IMMUNOBLOTTING; ION TRANSPORT; MALE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; WILD TYPE;

ANIMALS; CALCIUM-TRANSPORTING ATPASES; MALE; MICE; MICE, KNOCKOUT; MYOCARDIUM; NITRIC OXIDE SYNTHASE TYPE III; PHENOTYPE; SODIUM-POTASSIUM-EXCHANGING ATPASE;

ANIMALIA; MUS;

EID: 84879415373     PISSN: 11387548     EISSN: 18778755     Source Type: Journal    
DOI: 10.1007/s13105-012-0203-x     Document Type: Article

References (44)

1. Ait-Mamar B, Cailleret M, Rucker-Martin C et al (2005) The cytosolic phospholipase A2 pathway, a safeguard of β2-adrenergic cardiac effects in rat. J Biol Chem 280:18881-18890
2. Bambrick LL, Howlett EE, Feng ZP et al (1988) Radioligand binding to muscle homogenates to quantify receptor and ion channel numbers. J Pharmacol Methods 20:313-321
3. 1B- adrenoceptors. Braz J Med Biol Res 43:500-505
4. Barouch LA, Harrison RW, Skaf MW et al (2002) Nitric oxide regulates the heart by spatial confinement of nitric oxide synthase isoforms. Nature 416:337-339
5. Bartunek J, Weinberg EO, Tajima M et al (2000) Chronic N(G)-nitro-l-arginine methyl ester-induced hypertension: novel molecular adaptation to systolic load in absence of hypertrophy. Circulation 101:423-429
6. Benz D, Cadet P, Mantione K et al (2002) Tonal nitric oxide and health: a free radical and a scavenger of free radicals. Med Sci Monit 1:RA1-RA4
7. Champion HC, Georgakopoulos D, Takimoto E et al (2004) Modulation of in vivo cardiac function by myocyte-specific nitric oxide synthase-3. Circ Res 94:657-663
8. Chen Y, Traverse JH, Du R et al (2002) Nitric oxide modulates myocardial oxygen consumption in the failing heart. Circulation 106:273-279
9. Feron O, Belhassen L, Kobzik L et al (1996) Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271:22810-22814
10. Flaherty MP, Brown M, Grupp IL et al (2007) eNOS deficient mice develop progressive cardiac hypertrophy with altered cytokine and calcium handling protein expression. Cardiovasc Toxicol 7:165-177
11. Gkaliagkousi E, Ferro A (2011) Nitric oxide signalling in the regulation of cardiovascular and platelet function. Front Biosci 16:1873-1897
12. Graebe M, Brond L, Christensen S et al (2004) Chronic nitric oxide synthase inhibition exacerbates renal dysfunction in cirrhotic rats. Am J Physiol Ren Physiol 286:F288-F297
13. +-ATPase α-subunit gene expression in hypertension. Science 241:221-223
14. Hirst FX, Robson T (2011) Nitric oxide physiology and pathology. Methods Mol Biol 704:1-13
15. +-ATPase isoforms to oxidants. Biochim Biophys Acta 1190:108-114
16. Hummel SG, Fischer AJ, Martin SM et al (2006) Nitric oxide as a cellular antioxidant: a little goes a long way. Free Radic Biol Med 40:501-506
17. +-ATPase and its susceptibility to nitric oxide-deficient hypertension in rats. Clin Exp Pharmacol Physiol 34:617-623
18. Jo H, Otani H, Jo F et al (2011) Inhibition of nitric oxide synthase uncoupling by sepiapterin improves left ventricular function in streptozotocin-induced diabetic mice. Clin Exp Pharmacol Physiol 38:485-493
19. Khan SA, Skaf MW, Harrison RW et al (2003) Nitric oxide regulation of myocardial contractility and calcium cycling: independent impact of neuronal and endothelial nitric oxide synthases. Circ Res 92:1322-1329
20. Kim JS, Choi KC, Jeong MH et al (2006) Increased expression of sodium transporters in rats chronically inhibited of nitric oxide synthesis. J Korean Med Sci 21:1-4
21. Kopkan L, Hess A, Husková Z et al (2010) High-salt intake enhances superoxide activity in eNOS knockout mice leading to the development of salt sensitivity. Am J Physiol Ren Physiol 299:F656-F663
22. Li W, Mital S, Ojaimi C et al (2004) Premature death and age-related cardiac dysfunction in male eNOS-knockout mice. J Mol Cell Cardiol 37:671-680
23. +-ATPase. Am J Physiol Cell Physiol 284:C1550-C1560
24. Nediani C, Raimondi L, Borchi E et al (2011) Nitric oxide/reactive oxygen species generation and nitroso/redox imbalance in heart failure: from molecular mechanisms to therapeutic implications. Antioxid Redox Signal 14:289-331
25. +-ATPase inhibition in microssomes from rat heart. Biochem Pharmacol 33:47-53
26. +-ATPase isoform expression in rat heart. Antioxid Redox Signal 6:914-923
27. +-ATPase inhibition by 2-methoxy-3,8,9-trihydroxy coumestan. Bioorg Med Chem 16:8801-8805
28. Quintas LEM, Cunha VMN, Scaramello CB et al (2005) Adaptive expression pattern of different proteins involved in cellular calcium homeostasis in denervated rat vas deferens. Eur J Pharmacol 525:54-59
29. +-ATPase α isoforms expression in stroke-prone spontaneously hypertensive rat heart ventricles: effect of salt loading and lacidipine treatment. Eur J Pharmacol 565:151-157
30. Reifenberger MS, Arnett KL, Gatto C et al (2008) The reactive nitrogen species peroxynitrite is a potent inhibitor of renal Na-K-ATPase activity. Am J Physiol Ren Physiol 295:F1191-F1198
31. Schaffazick N, Amaral LS, Fonseca TF et al (2010) Effect of heparin treatment on the expression and activity of different ion-motive P-type ATPase isoforms from mouse extensor digitorum longus muscle during degeneration and regeneration after Bothrops jararacussu venom injection. Toxicon 55:52-60
32. +)-activated ATPase. XLII. Evidence for two classes of essential sulfhydryl groups. Biochim Biophys Acta 522:602-613
33. Scrogin KE, Hatton DC, Chi Y (1998) Chronic nitric oxide inhibition with l-NAME: effects on autonomic control of the cardiovascular system. Am J Physiol 274:R367-R374
34. Shesely EG, Maeda N, Kim HS et al (1996) Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc Natl Acad Sci 93:13176-13181
35. Vlkovicová J, Javorková V, Mézesová L et al (2008) Regulatory role of nitric oxide on the cardiac Na, K-ATPase in hypertension. Physiol Res 57(Suppl 2):S15-S22
36. Vrbjar N, Bernátová I, Pechánová O (1999) Changes of sodium and ATP affinities of the cardiac (Na, K)-ATPase during and after nitric oxide deficient hypertension. Mol Cell Biochem 202:141-147
37. Vrbjar N, Bernátová I, Pechánová O (1999) Functional alterations of cardiac (Na, K)-ATPase in l-NAME induced hypertension. Gen Physiol Biophys 18(Suppl 1):10-12
38. Vrbjar N, Javorková V, Pechánová O (2002) Changes of sodium and ATP affinities of the renal Na, K-ATPase during and after nitric oxide-deficient hypertension. Physiol Res 51:475-481
39. Vrbjar N, Pechánová O (2002) Sodium and ATP affinities of the cardiac (Na, K)-ATPase in relation to nitric oxide synthesis in spontaneously hypertensive rats. Life Sci 71:1751-1761
40. Xie ZJ, Wang JH, Askari A et al (1990) Studies on the specificity of the effects of oxygen metabolites on cardiac sodium pump. J Mol Cell Cardiol 22:911-920
41. Xu KY, Kuppusamy SP, Wang JQ et al (2003) Nitric oxide protects cardiac sarcolemmal membrane enzyme function and ion active transport against ischemia-induced inactivation. J Biol Chem 278:41798-41803
42. +-ATPase. Ann N Y Acad Sci 834:680-683
43. 2+-ATPase function by direct attack on the ATP binding site. Circ Res 80:76-81
44. Zhou L, Burnett AL, Huang PL et al (2002) Lack of nitric oxide synthase depresses ion transporting enzyme function in cardiac muscle. Biochem Biophys Res Commun 294:1030-1035